Stock NOVABAY PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar NovaBay Pharmaceuticals, Inc. Nyse

Equities

US66987P1021

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for NovaBay Pharmaceuticals, Inc.
05-09 NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-09 Earnings Flash (NBY) NOVABAY PHARMACEUTICALS Reports Q1 Revenue $2.63M, vs. Street Est of $3.28M MT

Chart calendar NovaBay Pharmaceuticals, Inc.

ddf918faac073356a6b.EqyEt2Ru8vJi4H1KSTYT7SzmhfeaKmaARVYbt3cxMKk.QcG38wEprboqjxgwDX1Jvhmnw4HoRiLhByV14QJ8fcBD9M7eJxucthOyOA~88d7af009d229d52d580acf211b53ce9

Upcoming events on NovaBay Pharmaceuticals, Inc.

2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on NovaBay Pharmaceuticals, Inc.

2024-05-30 Reverse Split: 1 of 35
2024-05-28 14:00 Annual General Meeting
2024-05-09 16:30 Q1 2024 Earnings Call
2024-05-09 16:05 Q1 2024 Earnings Release
2024-03-26 16:30 Q4 2023 Earnings Call
2024-03-26 16:05 Q4 2023 Earnings Release
2022-11-15 Reverse Split: 1 of 35
2022-08-11 16:30 Interim 2022 Earnings Call
2022-08-11 16:05 Interim 2022 Earnings Release
2022-05-12 16:30 Q1 2022 Earnings Call
2022-05-12 16:05 Q1 2022 Earnings Release
2022-03-29 16:30 FY 2021 Earnings Call
2022-03-29 16:05 FY 2021 Earnings Release
2022-01-31 14:00 Extraordinary Shareholders Meeting - Third Call
2022-01-13 Extraordinary Shareholders Meeting - Second Call
2022-01-10 07:00 H.C. Wainwright BioConnect Conference
2021-12-16 Extraordinary Shareholders Meeting - First Call
2021-11-11 16:30 Q3 2021 Earnings Call
2021-11-11 16:05 Q3 2021 Earnings Release
2021-09-29 16:30 Acquisition of DERMAdoctor, LLC by NovaBay® Pharmaceuticals, Inc Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		6,60
6,97
-5.32%		9,93
10,5
-5.39%		8,42
9,14
-7.82%		14,4
14,2
1.22%		14,7
14,4
2.26%
13,6

EBITDA
Million USD		Released
Forecast
Spread 		-9,34
-8,30
-12.47%		-6,38
-5,70
-11.84%		-8,74
-6,80
-28.57%		-7,20
-4,50
-59.93%		-7,39
-5,50
-34.42%
-4,40

EBIT
Million USD		Released
Forecast
Spread 		-9,40
-8,99
-4.56%		-6,43
-6,48
0.76%		-8,86
-8,59
-3.17%		-7,68
-5,76
-33.33%		-7,60
-6,20
-22.52%
-4,50

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,65
-8,79
-9.81%		-11,0
-11,1
0.86%		-5,82
-8,59
32.16%		-10,6
-5,97
-77.84%		-9,64
-9,50
-1.47%
-5,42

Net income
Million USD		Released
Forecast
Spread 		-10,5
-8,80
-19.24%		-11,0
-11,1
0.82%		-6,56
-8,59
23.6%		-16,3
-5,97
-172.67%		-16,7
-9,50
-75.76%
-5,42

EPS
USD		Released
Forecast
Spread 		-588
-521
-12.94%		-380
-392
3.12%		-184
-221
16.67%		-353
-142
-149.38%		-139
-80,9
-71.43%
-5,95

Announcement Date26/03/2025/03/2129/03/2230/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		2,63
3,26
-19.36%		3,05
3,51
-13.25%		3,83
3,74
2.3%		3,64
4,73
-22.98%		3,12
3,20
-2.38%		4,61
3,68
25.44%		3,27
3,55
-7.9%		3,73
3,40
9.62%		2,63
3,28
-19.79%
3,16


3,56


4,28


3,84


4,46

EBITDA
Million USD		Released
Forecast
Spread 		-2,35
-3,10
24.13%		-2,03
-2,30
11.65%		-0,34
-1,30
74%		-2,57
0,00
- 		-1,68
-1,80
6.5%		-1,30
-1,60
18.5%		-1,07
-1,40
23.93%		-3,34
-1,60
-108.81%		-2,42
-1,10
-120.36%
-1,00


-0,80


-0,30


-0,20


0,10

EBIT
Million USD		Released
Forecast
Spread 		-2,38
-2,90
17.72%		-2,15
-2,53
14.94%		-0,46
-1,95
76.56%		-2,69
-0,76
-253.82%		-1,73
-2,10
17.43%		-1,36
-2,09
35.17%		-1,12
-1,65
32.16%		-3,39
-2,00
-69.55%		-2,44
-1,32
-84.55%
-1,12


-0,74


-0,22


-0,84


-0,29

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-0,11
-2,15
94.83%		-2,16
-2,38
9.45%		-0,14
-1,80
92.44%		-8,21
-0,76
-979.74%		-1,74
-2,10
17.19%		-2,04
-2,09
2.58%		-1,76
-1,65
-6.81%		-4,11
-2,00
-105.4%		-3,09
-1,32
-134.09%
-1,12


-0,74


-0,22


-0,84


-0,29

Net income
Million USD		Released
Forecast
Spread 		-0,11
-2,15
94.83%		-2,16
-2,38
9.45%		-5,79
-1,80
-221.83%		-8,21
-0,76
-979.74%		-1,74
-2,10
17.19%		-4,03
-2,09
-92.92%		-1,76
-1,65
-6.81%		-9,17
-2,00
-358.45%		-3,59
-1,32
-172.27%
-1,12


-0,74


-0,22


-0,84


-0,29

EPS
USD		Released
Forecast
Spread 		0,00
-36,8
- 		-49,0
-42,9
-14.29%		-123
-36,8
-233.33%		-152
-12,8
-1086.3%		-29,8
-31,9
6.59%		-44,5
-19,4
-128.83%		-13,0
-14,2
8.64%		-46,6
-10,5
-343.33%		-5,25
-5,25
0%
-1,23


-0,70


-0,18


-0,88


-0,35

Announcement Date12/05/2211/08/2214/11/2230/03/2311/05/2310/08/2309/11/2326/03/2409/05/24-----

Upcoming sector events for NovaBay Pharmaceuticals, Inc.

2024-07-15 01:45 ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
2024-07-24 LONZA GROUP AG: Q2 2024 Earnings Release
2024-07-25 01:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
2024-07-25 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
2024-07-26 01:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for NovaBay Pharmaceuticals, Inc.

2024-05-29 16:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
2024-05-23 07:00 CUREVAC N.V.: Q1 2024 Earnings Release
2024-05-22 01:00 EVOTEC SE: Q1 2024 Earnings Release
2024-05-21 17:14 ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-17 02:00 BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 16:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 16:05 KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Stock
  5. Calendar NovaBay Pharmaceuticals, Inc.